Jamie Sulley

Dr. Sulley has 32 years of experience in biotech and pharmaceutical industry experience. Prior to joining Secura Bio, she was President and Member of the Board of Directors of Tamir Biotechnology (acquired by Orgenesis), Chief Operating Officer of Tensys Medical (acquired by Shanshi), General Manager for Pharmalink Consulting (acquired by Genpact), and former President of TCSI and JASA. She has grown and expanded pharmaceutical and med tech companies providing global leadership and support for FDA, EMA, MHRA and other health agency regulatory activities at the corporate level. Dr. Sulley has brought drug development programs from proof of concept through to global commercialization for New Chemical Entity (NCE), 505(b)(1) and 505(b)(2) products that have encompassed small molecules, biologics, and combination products leveraging her experience as an accredited FDA reviewer. She holds BS and PHD in Chemistry and a Masters in Public Health from University of Liverpool.